Certolizumab pegol Recruiting Phase 4 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03100253Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation
NCT02466581Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity
NCT01602302Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
NCT02242474Anti-TNF╬▒ Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis